Communication
RSC Advances
Notes and references
1 M. Iwaoka, Antioxidant Organoselenium Molecules, in
Organoselenium Chemistry: Between Synthesis and
Biochemistry, ed. C. Santi, Bentham Science Publishers,
2014, p. 361.
2 M. J. Parnham and H. Sies, Biochem. Pharmacol., 2013, 86,
1248.
3 (a) G. Mugesh, W.-W. du Mont and H. Sies, Chem. Rev., 2001,
101, 2125; (b) B. J. Bhuyan and G. Mugesh, Biological and
Biochemical Aspects of Selenium Compounds, in
Organoselenium Chemistry: Synthesis and Reactions, ed. T.
Wirth, WILEY-VCH, 2012, p. 361; (c) D. Pietrella,
Antimicrobial Activity of Organoselenium Compounds, in
Organoselenium
Chemistry:
Between
Synthesis
and
Biochemistry, ed. C. Santi, Bentham Science Publishers,
2014, p. 328; (d) B. K. Sarma and G. Mugesh, J. Am. Chem.
Soc., 2005, 127, 11477; (e) K. P. Bhabak and G. Mugesh,
Chem.–Eur. J., 2009, 15, 9846; (f) K. Selvakumar, P. Shah,
H. B. Singh and R. J. Butcher, Chem.–Eur. J., 2011, 17,
12741; (g) K. Satheeshkumar and G. Mugesh, Chem.–Eur. J.,
2011, 17, 4849; (h) V. P. Singh, H. B. Singh and
R. J. Butcher, Eur. J. Org. Chem., 2011, 5485; (i) K. Bijian,
Z. Zhang, B. Xu, S. Jie, B. Chen, Sh. Wan, J. H. Wu, T. Jiang
and A. A. Alaoui-Jamali, Eur. J. Med. Chem., 2012, 48, 143;
(j) C. Santi, R. Di Lorenzo, C. Tidei, L. Bagnoli and
Scheme 4 Alkyl and aryl benzizoselenazol-3(2H)-on analogues.
´
T. Wirth, Tetrahedron, 2012, 68, 10530; (k) M. Zielinska-
´
˙
Błajet, P. J. Boratynski, J. Palus and J. Skarzewski,
Tetrahedron, 2013, 69, 10223; (l) I. J. Kade, B. D. Balogun
and J. B. T. Rocha, Chem.-Biol. Interact., 2013, 206, 27; (m)
Z. Luo, L. Liang, J. Sheng, Y. Pang, J. Li, L. Huang and
X. Li, Bioorg. Med. Chem., 2014, 22, 1355.
4 (a) J. He, D. Li, K. Xiong, Y. Ge, H. Jin, G. Zhang, M. Hong,
Y. Tian, J. Yin and H. Zeng, Bioorg. Med. Chem., 2012, 20,
3816; (b) Z. Luo, J. Sheng, Y. Sun, Ch. Lu, J. Yan, A. Liu,
H. Luo, L. Huang and X. Li, J. Med. Chem., 2013, 56, 9089;
(c) F. Mao, J. Chen, Q. Zhou, Z. Luo, L. Huang and X. Li,
Bioorg. Med. Chem., 2013, 23, 6737.
5 D. Bartolini, S. Ciffolilli, M. Piroddi, G. Murdolo, C. Tortoioli
and F. Galli, Biochemistry and Nutrition of Selenium: From
Inorganic Forms to Endogenous Proteins, in Organoselenium
Chemistry: Between Synthesis and Biochemistry, ed. C. Santi,
Bentham Science Publishers, 2014, p. 268.
Fig. 1 Reactivity of the tested “ebselen-like” catalysts.
transformation of 23 to 24. Also good result was obtained for
p-methoxy group, near 90% of conversion. In the same time
unsubstituted phenyl group gave only 10% change of concen-
tration of 23.
´
´
6 (a) J. Scianowski and Z. Ranski, Electrophilic Selenium
Reagents: Addition to Double Bonds and
Selenocyclizations, in Organoselenium Chemistry: Between
Synthesis and Biochemistry, ed. C. Santi, Bentham Science
Publishers, 2014, p. 8; (b) C. Santi and C. Tidei, Addition
Reactions with Formation of Carbon–Sulfur and Carbon
Selenium Bonds, in Comprehensive Organic Synthesis, ed. A.
G. Molander and P. Knochel, Elsevier, Oxford, 2nd edn,
2014, vol. 7, p. 605.
Conclusions
A new method for the preparation of benzisoselenazol-3(2H)-
one analogues has been developed. A wide range of N-alkyl and
N-aryl derivatives have been obtained. A plausible mechanism
for the formation of ebselen derivatives was proposed. All
compounds were tested by the NMR assay that highlighted the
higher activity of alkyl and aryl analogues as compared to
ebselen. The aryl derivatives substituted in the para position
shown the highest antioxidant activity.
´
7 (a) J. Scianowski, Tetrahedron Lett., 2005, 46, 3331; (b)
´
´
J. Scianowski, Z. Ranski and A. Wojtczak, Eur. J. Org.
´
´
Chem., 2006, 14, 3216; (c) Z. Ranski, J. Scianowski and
A. Wojtczak, Tetrahedron: Asymmetry, 2008, 19, 223; (d)
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 48959–48962 | 48961